Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts

NCT: NCT07534865 · RECRUITING

NCT IDNCT07534865
StatusRECRUITING
Start Date2026-05-01
Completion2028-12-01

Brief Summary

Hyperthermia treatment (hyperthermia) refers to treating diseases with temperature (39-45 ° C) beyond normal body temperature,. It has been reported that local warming at 44 ° C is able to effectively mobilize the body's immunity and clear HPV infected lesions, such as condyloma acuminatum and verruca vulgaris, etc. Significant progress has been made in the application of hyperthermia for viral skin diseases. Clinically, the addition of hydrogen peroxide solution can enhance the efficacy of hyperthermia in treating HPV infection. As a common transdermal drug delivery method, microneedles can increase drug penetration and thereby further improve treatment outcomes. Based on these findings, this study aims to explore an adjunctive approach to hyperthermia for treating viral warts to further enhance therapeutic efficacy. This study employs a randomized, parallel-group, assessor-blinded design. Participants will be randomly assigned to three groups: hyperthermia alone, hyperthermia combined with microneedle patch (loaded with 0.9% saline), and hyperthermia combined with hydrogen peroxide microneedle patch (experimental group). An adaptive design will be adopted. The sample size is estimated at 70 participants per group, accounting for a potential 20% dropout rate. Interim analyses will be conducted during follow-up, and enrollment will be stopped when a positive result is reached for the primary efficacy endpoint (cure rate), at which point the sample size will be adjusted accordingly.

Frequently Asked Questions

What is Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts?

Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts is a clinical trial registered under NCT07534865. Current status: RECRUITING.

What is the status of NCT07534865?

The current status of NCT07534865 (Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts) is: RECRUITING.

When did Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts start?

Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts started on 2026-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.